Connect Biopharma is trading at $2.08 (5.8% up) in pre-market, extending a rebound seen late last week amid supportive macro risk-on sentiment and higher U.S. index futures.
- The move appears tied to broader market strength, with no fresh company-specific catalysts or fundamental news reported overnight.
- Current price action is consistent with prior gains noted during the recent market-wide recovery.